Administration of GMI. ganglioside restores the dopamine content in striatum after chronic treatment with MPTP-Reference-Cited by-同舟云学术

Administration of GMI. ganglioside restores the dopamine content in striatum after chronic treatment with MPTP

Published:1986-09 Issue:9 Volume:25 Page:1075-1077
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Hadjiconstantinou N.,Rossetti Z.L.,Paxton R.C.,Neff N.H.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference10 articles.

1. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Burns,1983

2. Epinephrine: A potential neurontransmitter in retina;Hadjiconstantinou;J. Neurochem,1983

3. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetranydropyridine in mice;Heikkila;Science,1984

4. Effects of GMI. ganglioside on developing and mature serotonin and noradzenaline neurons lesioned by selective neurotoxins;Jonsson;J Neurosci Res,1984

5. Reduction of cerebral edema with GMI ganglioside;Karpiak;J Neurosci Res,1984

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease Brain;2024-07-22

2. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction—Relevance to Parkinson’s Disease;International Journal of Molecular Sciences;2024-03-15

3. Functional Impairment of the Nervous System with Glycolipid Deficiencies;Advances in Neurobiology;2022-10-19

4. Gangliosides in Neurodegenerative Diseases;Advances in Neurobiology;2022-10-19

5. A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson’s disease;Glycoconjugate Journal;2021-05-26